Phase Advance and QNova Capital Enter Strategic Alliance, Using Predictive AI To Select High-Potential Drug Candidates
The predictive AI modeling startup and the new investment fund of QNova Life Sciences are joining forces to select preclinical drug candidates with AI-powered insights. Phase Advance, a pharma modeling…